Rome – – November 03, 2026 --

The START Center for Cancer Research will open its first Italian early-phase oncology trial site inside Rome's IRCCS Istituto Nazionale Tumori Regina Elena, under a strategic partnership with the public hospital organization Istituti Fisioterapici Ospitalieri (IFO). The site will be fully integrated into START's network and will have access to its global trial portfolio from day one.

SMITHFIELD, R.I. – November 03, 2026 -- Acclaro Medical will showcase UltraClear, which it describes as the world's first 2910 nm cold ablative fiber laser, at the American Society for Dermatologic Surgery (ASDS) Annual Meeting, held November 4-8 in San Diego, California.

Copenhagen – November 03, 2026 -- Cambiotics ApS has enrolled the first participant in its first human clinical trial, testing whether its probiotic strain 46-SL1 changes serum PFAS concentrations in 70 firefighters with prior occupational exposure.

Duluth, Georgia – November 03, 2026 -- Bridge to Life Ltd. has secured a Health Canada Medical Device License for its VitaSmart HOPE System and an FDA Breakthrough Device Designation for investigational use in donor intestines, widening the commercial reach of its organ perfusion platform in North America.

Dusseldorf – November 03, 2026 -- More than 500 start-ups will exhibit among several thousand exhibitors at MEDICA 2026, held 16-19 November in Düsseldorf, and the 15th MEDICA START-UP COMPETITION will stage its pitch final on the new MEDICA MAIN STAGE in Hall 12 for the first time.

Potomac, Md. – November 03, 2026 -- Creatv MicroTech is applying for CLIA approval for its LifeTracDx blood test and plans to file for FDA approvals across multiple cancer diagnostic applications, according to a profile of founder Cha-Mei Tang issued by The Inner Circle.

Vancouver – November 03, 2026 -- The International Society for Cell & Gene Therapy (ISCT) is renaming its Institute of Training & Development the ISCT Academy of Training & Development, three years after the program launched in 2023.

ISCT CEO Queenie Jang said the program has outgrown the institute label and that the new name reflects its scale and global reach.

Singapore – November 02, 2026 -- Ultima Genomics' UG200 Sequencing Platform has been selected for the SG-INSIGHT cohort of Phase III of Singapore's National Precision Medicine (NPM) program, which will cover about 450,000 individuals. The company calls it its first major win supporting a national-scale clinical whole genome sequencing initiative. Financial terms were not disclosed.

Perth – November 01, 2026 -- Orthocell Limited (ASX: OCC) sold 92 units of its Remplir nerve repair wrap in the U.S. in October 2026, generating AU$279,000 in revenue, an 84% increase on the average monthly sales of 50 units in Q1 FY27.

It is the strongest month of U.S. sales since the product launched. The company released the figures ahead of its Annual General Meeting on 6 November 2026. Standard quarterly reporting will continue after the meeting.

TORONTO – October 31, 2026 -- Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) has signed a supply and distribution agreement with the iMRI Division of Cook Medical, adding a second U.S. capital equipment channel for its TULSA-PRO system while keeping recurring treatment kit and service revenue in-house.